$AZTA News

Last published 1d ago

1d agoAZTAAzenta, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
1d agoAZTAAzenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026.PR NewswireAzenta, Inc. (Nasdaq: AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2026....
1w agoAZTAAzenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis CapabilitiesPR NewswireExclusive licensing agreement with Elegen and acquisition of SynPlexity strengthen gene synthesis capabilities, expand high-throughput discovery workflows, and position GENEWIZ for long-term growthBURLINGTON, Mass.,
2w agoAZTAAzenta Announces Fiscal 2026 Fourth Quarter and Full Year Conference Call and WebcastPR NewswireBURLINGTON, Mass., Oct. 28, 2026 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2026 earnings which ended on September 30, 2026, on Tuesday, November 10, 2026, after the
2mo agoAZTAAzenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical SystemsPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced that it has received repayment in full, prior to maturity, of the $35 million secured vendor loan...
2mo agoAZTA CG HAEAZENTA ANNOUNCES LEADERSHIP TRANSITIONPR NewswireAzenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus ...
3mo agoAZTAAzenta Q3'26 Earnings Conference Call and Webcast - AZENTA INCEarnings Call TranscriptsGreetings and welcome to Azenta Q3 2026 Fiscal Financial Results. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question and answer session. As a reminder, this co
3mo agoAZTAAzenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.PR NewswireAzenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2026. The results of B Medical Systems are reported ...
3mo agoCBT AZTACabot Corporation Announces Planned Leadership TransitionGlobeNewswireBOSTON, July 30, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) announced today that Sean Keohane has notified the Board of Directors of his decision to retire as President and Chief Executive Officer (CEO) of
3mo agoAZTAAzenta Announces Fiscal 2026 Third Quarter Conference Call and WebcastPR NewswireAzenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2026 earnings which ended on June 30, 2026, on Tuesday, August 4, 2026, after the...
4mo agoAZTAAzenta Completes Sale of B Medical SystemsPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced the completion of the previously disclosed sale of its B Medical Systems business to Thelema S.à r.l. The ...
5mo agoAZTAAzenta Publishes 2025 Environmental, Social, and Governance (ESG) ReportPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, demonstrating continued ...
6mo agoAZTAAzenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029PR NewswireAzenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2026. The results of B Medical Systems are...
6mo agoAZTAAzenta Announces Fiscal 2026 Second Quarter Conference Call and WebcastPR NewswireAzenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2026 earnings which ended on March 31, 2026, on Wednesday, May 6, 2026, before the...
7mo agoAZTAAzenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics ExecutionPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced the appointment of Trey Martin as President of its Multiomics business, effective April 6, 2026. In this...
8mo agoAZTAAzenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository CapabilitiesPR NewswireAzenta, Inc. (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has...
8mo agoAZTAAzenta to Participate in Raymond James 47th Annual Institutional Investor ConferencePR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Raymond James 47th Annual Institutional Investor Conference,...
9mo agoAZTAAzenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research InfrastructurePR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with Frontier Space, a pioneer in commercial space-based research systems, to...
9mo agoAZTAAzenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025PR NewswireAzenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2025. The results of B Medical Systems are...
9mo agoAZTAAzenta Announces Fiscal 2026 First Quarter Conference Call and WebcastPR NewswireAzenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2026 earnings which ended on December 31, 2025, on Wednesday, February 4, 2026, before ...
10mo agoAZTAAzenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.PR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B...
11mo agoAZTAAzenta Authorizes $250 Million Share Repurchase ProgramPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced that its Board of Directors has approved a share repurchase program under which the company may...
11mo agoAZTAAzenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025PR NewswireAzenta, Inc. (Nasdaq: AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2025. Quarter Ended Year...
12mo agoAZTAAzenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and WebcastPR NewswireAzenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2025 earnings which ended on September 30, 2025, on Friday, November...
1y agoAZTAAzenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic CancerPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with the PRECEDE Foundation, an international, multi-institutional collaborative...
1y agoAZTAAzenta to Host Investor Day at its Biorepository Facility in Indianapolis, IndianaPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced that it will host an Investor Day on Wednesday, December 10, 2025, at the Company's biorepository...
1y agoAZTAAzenta, Inc. (AZTA) Q3 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoAZTAAzenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 GuidancePR NewswireAzenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2025. The results of B Medical Systems are treated...
1y agoAZTAAzenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in NephrologyPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics, ...
1y agoAZTAFresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease CarePR NewswireFresenius Medical Care today announced that Frenova, the company's third-party clinical research organization, along with Nephronomics, a renal...
1y agoAZTAAzenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferencePR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 10th Annual Needham Virtual MedTech & Diagnostics 1x1...
1y agoAZTAAzenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and WebcastPR NewswireAzenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2025 earnings which ended on June 30, 2025, on Tuesday August 5, 2025, before the...
1y agoAZTAAzenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy DevelopmentPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership between GENEWIZ from Azenta Life Sciences, a global provider of multiomics and...
1y agoAZTAAzenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025PR NewswireAzenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2025. The results of B Medical Systems are...
1y agoAZTAAzenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and WebcastPR NewswireAzenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2025 earnings which ended on March 31, 2025, on Wednesday May 7, 2025, before the...
1y agoAZTAAzenta Publishes its 2024 Environmental, Social, & Governance (ESG) ReportPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, highlighting the...
1y agoAZTAAzenta to Participate in the Virtual KeyBanc Capital Markets Healthcare ForumPR NewswireAzenta, Inc. (Nasdaq: AZTA) announced that Lawrence Y. Lin, Executive Vice President and Chief Financial Officer, will participate in the Virtual...
1y agoAZTAAzenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024PR NewswireAzenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2024. The results of B Medical Systems are...
1y agoAZTA TRDAAzenta Announces the Election of Dipal Doshi to its Board of DirectorsPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) and a recognized leader...
1y agoAZTAAzenta Announces Fiscal 2025 First Quarter Earnings Conference Call and WebcastPR NewswireAzenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2025 earnings which ended on December 31, 2024, on Wednesday February 5, 2025, before...
1y agoAZTAUK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research ExcellencePR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale...
1y agoAZTAAzenta to Participate in Stephens Annual Investment ConferencePR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Stephens Annual Investment Conference, on Wednesday November...
1y agoAZTAAzenta, Inc. (AZTA) Q4 2024 Earnings Call TranscriptEarnings Call Transcripts
1y agoAZTAAzenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFOPR NewswireAzenta, Inc. (Nasdaq: AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2024. Fiscal Year 2024...
2y agoAZTAAzenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and WebcastPR NewswireAzenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2024 earnings which ended on September 30, 2024, on Tuesday, November...
2y agoAZTA BV LVWRAzenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive ValuePR NewswireAzenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced the appointment of three new independent directors to its Board. William...
2y agoAZTAAzenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing TestPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes...
2y agoAZTAAZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEOPR NewswireAzenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P. Marotta will join the Company as President and CEO effective...
2y agoAZTAGENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week EventPR NewswireAzenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th...
2y agoAZTAAzenta, Inc. (AZTA) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts